Scanning ultrasound removes amyloid-β and restores memory in an Alzheimer’s disease mouse model
The DOI matches its Crossref record; 40 of the 40 references it cites were found in a registry or an index.
Abstract
Repeated scanning ultrasound in the absence of a therapeutic agent removes amyloid-β and restores memory in an Alzheimer’s disease mouse model.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Our results support previous studies showing improved behaviour in AD mouse models associated with enhanced microglial amyloid plaque phagocytosis in response to scanning ultrasound69, and treatment with IL-33 that signals exclusively via MyD8870.”
From Transcriptional signature in microglia associated with Aβ plaque phagocytosis (2021) · cites this paper as [69]
Citations
Cites
1 retracted
RETRACTED ARTICLE: A specific amyloid-β protein assembly in the brain impairs memory
Lesné, S., Koh, M. T., Kotilinek, L., Kayed, R., Glabe, C. G., Yang, A., Gallagher, M., & Ashe, K. H. (2006) · Nature · doi:10.1038/nature04533 · Cited by 2,769
RetractedSoluble protein oligomers in neurodegeneration: lessons from the Alzheimer's amyloid β-peptide
Haass, C., & Selkoe, D. J. (2007) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm2101 · Cited by 4,744
Phases of Aβ-deposition in the human brain and its relevance for the development of AD
Thal, D. R., Rüb, U., Orantes, M., & Braak, H. (2002) · Neurology · doi:10.1212/wnl.58.12.1791 · Cited by 3,490 · cited 1×
“An entire series of sections was processed for Campbell-Switzer silver staining (36) using a protocol available online at http://neuroscienceassociates.”
MethodScheuner, D., Eckman, C., Jensen, M., Song, X., Citron, M., Suzuki, N., Bird, T. D., Hardy, J., Hutton, M., Kukull, W., et al. (1996) · Nature Medicine · doi:10.1038/nm0896-864 · Cited by 2,599
Decreased Clearance of CNS β-Amyloid in Alzheimer’s Disease
Mawuenyega, K. G., Sigurdson, W., Ovod, V., Munsell, L., Kasten, T., Morris, J. C., Yarasheski, K. E., & Bateman, R. J. (2010) · Science · doi:10.1126/science.1197623 · Cited by 2,078 · cited 1×
“Ab is elevated in the AD brain because of the increased production of this peptide and its impaired removal (4, 5).”
BackgroundDendritic Function of Tau Mediates Amyloid-β Toxicity in Alzheimer's Disease Mouse Models
Ittner, L. M., Ke, Y. D., Delerue, F., Bi, M., Gladbach, A., van Eersel, J., Wölfing, H., Chieng, B. C., Christie, M. J., Napier, I. A., et al. (2010) · Cell · doi:10.1016/j.cell.2010.06.036 · Cited by 1,821 · cited 1×
“At the age of 12 to 13 months, APP23 mice have a substantial plaque burden and spatial memory deficits (17).”
BackgroundSelf-citationTwo amyloid precursor protein transgenic mouse models with Alzheimer disease-like pathology
Sturchler-Pierrat, C., Abramowski, D., Duke, M., Wiederhold, K.-H., Mistl, C., Rothacher, S., Ledermann, B., Bürki, K., Frey, P., Paganetti, P. A., et al. (1997) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.94.24.13287 · Cited by 1,507
Amyloid-β and tau--a toxic pas de deux in Alzheimer’s disease
Ittner, L. M., & Götz, J. (2011) · Nature Reviews Neuroscience · doi:10.1038/nrn2967 · Cited by 1,269
Self-citationAlzheimer’s disease: Clinical trials and drug development
Mangialasche, F., Solomon, A., Winblad, B., Mecocci, P., & Kivipelto, M. (2010) · The Lancet Neurology · doi:10.1016/s1474-4422(10)70119-8 · Cited by 1,217 · cited 1×
“Recent therapeutic strategies have targeted both processes (6), including the inhibition of secretase enzymes to reduce Ab production, as well as active and, in particular, passive immunization approaches for boosting Ab clearance.”
The secretases: enzymes with therapeutic potential in Alzheimer disease
De Strooper, B., Vassar, R., & Golde, T. (2010) · Nature Reviews Neurology · doi:10.1038/nrneurol.2009.218 · Cited by 799 · cited 1×
“Inhibition of secretases affects additional substrates with potential off-target effects (7), and passive immunization may be costly once effectiveness is demonstrated in clinical trials (8).”
Background
Cited by
Items 201–300 of 514
Barzegar‐Fallah, A., Gandhi, K., Rizwan, S. B., Slatter, T. L., & Reynolds, J. N. J. (2022) · Pharmaceutics · doi:10.3390/pharmaceutics14102231 · Cited by 36
Ávila, J., Pallas‐Bazarra, N., Bolós, M., Sayas, C. L., & Hernández, F. (2016) · Expert Opinion on Therapeutic Targets · doi:10.1517/14728222.2016.1131269 · Cited by 38
Focused ultrasound therapy for movement disorders
Martínez‐Fernández, R., Paschen, S., del Álamo, M., Rodríguez‐Rojas, R., Pineda‐Pardo, J. A., Blesa, J., Kaplitt, M. G., Deuschl, G., & Obeso, J. A. (2025) · The Lancet Neurology · doi:10.1016/s1474-4422(25)00210-8 · Cited by 39
Targeted Magnetic Nanoparticles for Remote Magnetothermal Disruption of Amyloid‐β Aggregates
Loynachan, C. N., Romero, G., Christiansen, M. G., Chen, R., Ellison, R., O’Malley, T. T., Froriep, U. P., Walsh, D. M., & Anikeeva, P. (2015) · Advanced Healthcare Materials · doi:10.1002/adhm.201500487 · Cited by 38
Advances in Biological Application of and Research on Low-Frequency Ultrasound
Mei, L., & Zhang, Z. (2021) · Ultrasound in Medicine & Biology · doi:10.1016/j.ultrasmedbio.2021.06.005 · Cited by 37
van Schaik, P. E. M., Zuhorn, I. S., & Baron, W. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms23158418 · Cited by 37
Chen, L., Cruz, E., Oikari, L. E., Padmanabhan, P., Song, J. H., & Götz, J. (2022) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2022.114517 · Cited by 38
Self-citationLiu, M., Jevtic, S. D., Markham-Coultes, K., Ellens, N. P. K., O’Reilly, M. A., Hynynen, K., Aubert, I., & McLaurin, J. (2017) · Brain Research · doi:10.1016/j.brainres.2017.10.015 · Cited by 37
Hatch, R. J., Leinenga, G., & Götz, J. (2016) · PLOS ONE · doi:10.1371/journal.pone.0164278 · Cited by 34
“A single SUS treatment does not alter the short-term excitability of hippocampal CA1 neurons In our analysis we focused on CA1 pyramidal neurons as this region and cell type has previously been reported to play an important role in hippocampal-dependent memory tasks [18, 19], the function of which was improved followi…”
BackgroundMethodSelf-citationGenetic Variants and Oxidative Stress in Alzheimer’s Disease
Kowalska, M., Wize, K., Prendecki, M., Lianeri, M., Kozubski, W. P., & Dorszewska, J. (2020) · Current Alzheimer Research · doi:10.2174/1567205017666200224121447 · Cited by 36
McMahon, D., Mah, E., & Hynynen, K. (2018) · Scientific Reports · doi:10.1038/s41598-018-30825-8 · Cited by 37
Kong, C., & Chang, W. S. (2023) · Neurology International · doi:10.3390/neurolint15010018 · Cited by 37
“FUS induces the activation of microglia and astrocytes, which may increase phagocytosis of the amyloid plaques [31,32,41].”
BackgroundDeBay, D. R., Reid, G. A., Macdonald, I. R., Mawko, G., Burrell, S., Martin, E. V., Bowen, C. V., & Darvesh, S. (2017) · Brain Research · doi:10.1016/j.brainres.2017.07.009 · Cited by 37
Chen, P., Wei, K., & Liu, H.-L. (2015) · Human Vaccines & Immunotherapeutics · doi:10.1080/21645515.2015.1071749 · Cited by 33
“This phenomenon has recently been reconfirmed by Leinenga and Gotz, who found that it can restore memory functions of transgenic AD mice.(26) Importantly, this glial cell activation and Ab clearance process was found to not cause neuroinflammation, as neuroinflammation has long been”
ResultThakur, S. S., Ward, M. S., Popat, A., Flemming, N., Parat, M., Barnett, N. L., & Parekh, H. S. (2017) · PLoS ONE · doi:10.1371/journal.pone.0178305 · Cited by 35
Effects of exercise-induced apelin on muscle function and cognitive function in aged mice
Kwak, S. E., Cho, S. C., Bae, J. H., Lee, J., Shin, H. E., Di Zhang, D., Lee, Y.-I., & Song, W. (2019) · Experimental Gerontology · doi:10.1016/j.exger.2019.110710 · Cited by 32
Silburt, J., Lipsman, N., & Aubert, I. (2017) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1710761114 · Cited by 36
Elucidating the Effect of Static Electric Field on Amyloid Beta 1–42 Supramolecular Assembly
Muscat, S., Stojceski, F., & Danani, A. (2020) · Journal of Molecular Graphics and Modelling · doi:10.1016/j.jmgm.2020.107535 · Cited by 32
Innovative Therapeutic Strategies for Effective Treatment of Brain Metastases
Lim, M., Puttick, S. G., Houston, Z. H., Thurecht, K. J., Croft, P. K., Mahler, S. M., Rose, S., Jeffree, R. L., Mazzieri, R., Dolcetti, R., et al. (2019) · International Journal of Molecular Sciences · doi:10.3390/ijms20061280 · Cited by 32
Novel models for Parkinson’s disease and their impact on future drug discovery
Trigo‐Damas, I., del Rey, N. L., & Blesa, J. (2018) · Expert Opinion on Drug Discovery · doi:10.1080/17460441.2018.1428556 · Cited by 34
“Several attempts have been made to specifically target AD pathology with ultrasound, either to deliver an Aβ-specific antibody [105] to or just scanning over the skull to open the BBB throughout the brain [106], resulting in a reduction in plaque burden and monomeric and oligomeric Aβ species.”
BackgroundZhang, J., Chen, B., Lu, J., Wu, Y., Wang, S., Yao, Z., Zhu, L., Qiao, Y., Sun, Q., Qin, W., et al. (2019) · Aging Cell · doi:10.1111/acel.12978 · Cited by 35
“Researchers generally use SDS‐PAGE and Western blotting to analyze the Aβ oligomers, including the dimer, in human and mouse brain homogenates (Leinenga & Gotz, 2015; Lesne et al., 2013), but the SDS may affect the native Aβ oligomers like dimer in samples.”
MethodThe Blood-Brain Barrier in Alzheimer’s Disease
Storck, S. E., Hartz, A. M. S., & Pietrzik, C. U. (2020) · Handbook of experimental pharmacology · doi:10.1007/164_2020_418 · Cited by 32
Leinenga, G., Koh, W. K., & Götz, J. (2019) · Brain Research Bulletin · doi:10.1016/j.brainresbull.2019.08.002 · Cited by 31
Self-citationThalamotomy for essential tremor: FDA approval brings brain treatment with FUS to the clinic
Fishman, P. S. (2017) · Journal of Therapeutic Ultrasound · doi:10.1186/s40349-017-0096-9 · Cited by 32
Neuromodulation in the Treatment of Alzheimer’s Disease: Current and Emerging Approaches
Pople, C. B., Meng, Y., Li, D. Z., Bigioni, L., Davidson, B., Vecchio, L. M., Hamani, C., Rabin, J. S., & Lipsman, N. (2020) · Journal of Alzheimer s Disease · doi:10.3233/jad-200913 · Cited by 32
Effects of exercise‐induced beta‐hydroxybutyrate on muscle function and cognitive function
Kwak, S. E., Bae, J. H., Lee, J. H., Shin, H. E., Zhang, D., Cho, S. C., & Song, W. J. (2021) · Physiological Reports · doi:10.14814/phy2.14497 · Cited by 33
“Alteration percentage in Y-maze test is an index of cognitive function in mice (Kwak, Cho, et al., 2019; Leinenga & Gotz, 2015; Park et al., 2019).”
BackgroundThe Microglial Response to Neurodegenerative Disease
Song, W. M., & Colonna, M. (2018) · Advances in immunology · doi:10.1016/bs.ai.2018.04.002 · Cited by 30
Transcranial Low-Intensity Pulsed Ultrasound Stimulation Induces Neuronal Autophagy
Huang, X., Niu, L., Meng, L., Lin, Z., Zhou, W., Liu, X., Huang, J., Abbott, D., & Zheng, H. (2020) · IEEE Transactions on Ultrasonics Ferroelectrics and Frequency Control · doi:10.1109/tuffc.2020.3028619 · Cited by 30
“[34] R. Pandit, G. Leinenga, and J. Götz, “Repeated ultrasound treatment of tau transgenic mice clears neuronal tau by autophagy and improves behavioral functions,” Theranostics, vol. 9, no. 13, pp. 3754–3767, 2019.”
BackgroundInfluentialScanning ultrasound-mediated memory and functional improvements do not require amyloid-β reduction
Leinenga, G., To, X. V., Bodea, L., Yousef, J. M., Richter-Stretton, G. L., Palliyaguru, T., Chicoteau, A., Dagley, L. F., Nasrallah, F. A., & Götz, J. (2024) · Molecular Psychiatry · doi:10.1038/s41380-024-02509-5 · Cited by 32
Self-citationEffects of sound energy on proteins and their complexes
Kozell, A., Solomonov, A. V., & Shimanovich, U. (2023) · FEBS Letters · doi:10.1002/1873-3468.14755 · Cited by 30
“It was also found that US can be utilized to disaggregate amyloid plaques when using scanning US, enabling removal of amyloid-β [41,42].”
BackgroundMR-guided focused ultrasound in movement disorders and beyond: Lessons learned and new frontiers
Natera‐Villalba, E., Ruiz-Yanzi, M.-A., Gasca‐Salas, C., Matarazzo, M., & Martínez‐Fernández, R. (2024) · Parkinsonism & Related Disorders · doi:10.1016/j.parkreldis.2024.106040 · Cited by 30
Gutiérrez, M. I., Penilla, E. H., Leija, L., Vera, A., Garay, J. E., & Aguilar, G. (2017) · Advanced Healthcare Materials · doi:10.1002/adhm.201700214 · Cited by 31
Piezodynamic therapy: Mechanisms and biomedical applications
Wang, L., Zhang, S., Zhang, Y., & An, Q. (2023) · Nano Energy · doi:10.1016/j.nanoen.2023.108342 · Cited by 30
Transcranial pulse stimulation in Alzheimer's disease
Chen, X., You, J., Ma, H., Zhou, M., & Huang, C. (2023) · CNS Neuroscience & Therapeutics · doi:10.1111/cns.14372 · Cited by 33
“64 Whole brain low-intensity pulsed ultrasound therapy has been shown to significantly improve cognitive dysfunction in dementia mice by increasing the expression of endothelial oxide nitric synthase.”
BackgroundGraphene- and MXene-based materials for neuroscience: diagnostic and therapeutic applications
Zarepour, A., Karasu, Ç., Mir, Y., Nematollahi, M. H., Iravani, S., & Zarrabi, A. (2023) · Biomaterials Science · doi:10.1039/d3bm01114c · Cited by 28
McMahon, D., & Hynynen, K. (2018) · Theranostics · doi:10.7150/thno.25468 · Cited by 28
The Emergence of Functional Ultrasound for Noninvasive Brain–Computer Interface
Zheng, H., Niu, L., Qiu, W., Liang, D., Long, X., Li, G., Liu, Z., & Meng, L. (2023) · Research · doi:10.34133/research.0200 · Cited by 27
Herzer, S., Hagan, C., von Gerichten, J., Dieterle, V., Munteanu, B., Sandhoff, R., Hopf, C., & Nordström, V. (2018) · Frontiers in Molecular Neuroscience · doi:10.3389/fnmol.2018.00206 · Cited by 27
Noel, R. L., Batts, A. J., Ji, R., Pouliopoulos, A. N., Bae, S., Kline-Schoder, A. R., & Konofagou, E. E. (2023) · Scientific Reports · doi:10.1038/s41598-023-30466-6 · Cited by 27
Physical and toxicological profiles of human IAPP amyloids and plaques
Käkinen, A., Sun, Y., Javed, I., Faridi, A., Pilkington, E. H., Faridi, P., Purcell, A. W., Zhou, R., Ding, F., Lin, S., et al. (2018) · 中国科学通报:英文版 · doi:10.1016/j.scib.2018.11.012 · Cited by 29
“an Alzheimer’s disease mouse model by clearing amyloids via the lysosomes of energized microglia [45].”
BackgroundПавлов, А. Н., Dubrovsky, A. I., Koronovskii, A. A., Pavlova, O. N., SEMYACHKINA-GLUSHKOVSKAYA, O. V., & Kurths, J. (2020) · Chaos An Interdisciplinary Journal of Nonlinear Science · doi:10.1063/5.0011823 · Cited by 27
Hu, Z., Chen, S., Yang, Y., Gong, Y., & Chen, H. (2022) · IEEE Transactions on Biomedical Engineering · doi:10.1109/tbme.2022.3150781 · Cited by 30
“FUS-BBBO without any drugs was found to reduce the amyloid plaque and improve cognitive performance in Alzheimer’s disease mouse models [20].”
BackgroundBajracharya, R., Cruz, E., Götz, J., & Nisbet, R. M. (2022) · Journal of Controlled Release · doi:10.1016/j.jconrel.2022.07.026 · Cited by 28
Self-citationLessons Learned about Neurodegeneration from Microglia and Monocyte Depletion Studies
Lund, H., Pieber, M., & Harris, R. A. (2017) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2017.00234 · Cited by 28
“However, it is important to understand that microglia can be stimulated into removing existing amyloid plaques by a variety of means (Boissonneault et al., 2009; Leinenga and Götz, 2015; Iaccarino et al., 2016; Daria et al., 2017).”
BackgroundWeber‐Adrian, D., Kofoed, R. H., Silburt, J., Noroozian, Z., Shah, K., Burgess, A., Rideout, S., Kügler, S., Hynynen, K., & Aubert, I. (2021) · Scientific Reports · doi:10.1038/s41598-021-81046-5 · Cited by 30
Invasive and non-invasive therapies for Alzheimer’s disease and other amyloidosis
Pandey, G., & Ramakrishnan, V. (2020) · Biophysical Reviews · doi:10.1007/s12551-020-00752-y · Cited by 31
“Scanning ultrasound (SUS) is a noninvasive strategy that has lately been shown to reduce the plaque load and restore memory in an AD mouse model (Leinenga and Götz 2015).”
BackgroundMathew, A. S., Gorick, C. M., Thim, E. A., Garrison, W. J., Klibanov, A. L., Miller, G. W., Sheybani, N., & Price, R. J. (2020) · Bioengineering & Translational Medicine · doi:10.1002/btm2.10198 · Cited by 26
“Indeed, this may be the primary mechanism by which FUS promotes Aβ plaque clearance in Alzheimer's disease.(66) Similarly, neurogenesis observed after FUS may be attributable to tissue repair mechanisms preceded SI.”
BackgroundSEMYACHKINA-GLUSHKOVSKAYA, O. V., Karavaev, A. S., Prokhorov, M. D., Евгеньевна, Р. А., Borovkova, E. I., Yu.M., I., Hramkov, A. N., Kulminskiy, D. D., Игоревна, С. Н., Sergeev, K. S., et al. (2022) · Computational and Structural Biotechnology Journal · doi:10.1016/j.csbj.2022.12.019 · Cited by 26
Sonodynamic therapy induces oxidative stress, DNA damage and apoptosis in glioma cells
Sun, Y. L., Wang, H., Zhang, K., Liu, J., Wang, P., Wang, X., & Liu, Q. (2018) · RSC Advances · doi:10.1039/c8ra07099g · Cited by 28
Bok, J., Ha, J., Ahn, B. J., & Jang, Y. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms24010679 · Cited by 25
“001 mL/g Sonication duration: 6 s per spot Weekly for 6 or 7 weeks APP23 mice - ↑microglia Aβ lysosomal activity - ↑ albumin entering the brain, which binds to Aβ and facilitates Aβ uptake by microglia - ↑memory ability [120]”
BackgroundMethodInfluentialNanotherapy for Alzheimer's disease and vascular dementia: Targeting senile endothelium
D'Arrigo, J. S. (2017) · Advances in Colloid and Interface Science · doi:10.1016/j.cis.2017.12.002 · Cited by 29
Experimental Models of Tauopathy – From Mechanisms to Therapies
Götz, J. J., & Götz, J. (2019) · Advances in experimental medicine and biology · doi:10.1007/978-981-32-9358-8_28 · Cited by 24
Self-citationHe, J., Zhu, Y., Wu, C., Wu, J., Chen, Y., Yuan, M., Cheng, Z., Zeng, L., & Ji, X. (2023) · Journal of Neural Engineering · doi:10.1088/1741-2552/acb104 · Cited by 24
Kawasaki, T., Man, V. H., Sugimoto, Y., Sugiyama, N., Yamamoto, H., Tsukiyama∥, K., Wang, J., Derreumaux, P., & Nguyen, P. H. (2020) · The Journal of Physical Chemistry B · doi:10.1021/acs.jpcb.0c05385 · Cited by 25
Focused ultrasound neuromodulation
Meng, Y., Pople, C. B., Lea‐Banks, H., Hynynen, K., Lipsman, N., & Hamani, C. (2021) · International review of neurobiology · doi:10.1016/bs.irn.2021.06.004 · Cited by 26
Bathini, P., Sun, T., Schenk, M., Schilling, S., McDannold, N. J., & Lemere, C. A. (2022) · Biomolecules · doi:10.3390/biom12070951 · Cited by 30
“Although, FUS exposure contributes to an increase in the penetration of endogenous IgG and IgM antibodies from the periphery to the brain and stimulation of immune responses and microglial activation [26,47], the significant increase in glial immunoreactivity could be mainly due to the increased 07/2a mAb abundance in…”
BackgroundAllosteric Sensing of Fatty Acid Binding by NMR: Application to Human Serum Albumin
Jafari, N., Ahmed, R., Gloyd, M., Bloomfield, J., Britz‐McKibbin, P., & Melacini, G. (2016) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.6b00410 · Cited by 23
Multi-mechanical waves against Alzheimer’s disease pathology: a systematic review
Monteiro, F., Sotiropoulos, I., Carvalho, Ó. S. N., Sousa, N., & Silva, F. S. (2021) · Translational Neurodegeneration · doi:10.1186/s40035-021-00256-z · Cited by 24
“recognition, spatial, working, and short- and long-term memories) [36, 56, 58, 66], improved exploratory skills [36, 38, 57] and improved motor ability and coordination [66].”
BackgroundInfluentialYan, T., Wang, X., Liu, S., Fan, D., Xu, X., Zeng, Q., Xie, H. M., Yang, X., Zhu, S., Ma, X., et al. (2022) · Small Methods · doi:10.1002/smtd.202201105 · Cited by 23
Finke, J., & Banks, W. (2017) · Human Antibodies · doi:10.3233/hab-160306 · Cited by 18
“Sur-prisingly, A β clearance and cognitive benefits in AD transgenic mice are also reported after ultrasonic pulsing when no drug was administered [77,89].”
InfluentialReal-Time HIFU Treatment Monitoring Using Pulse Inversion Ultrasonic Imaging
Shin, E.-J., Kang, B., & Chang, J. H. (2018) · Applied Sciences · doi:10.3390/app8112219 · Cited by 23
“High-intensity focused ultrasound (HIFU) has attracted considerable attention as a non-invasive surgical tool; its applications range from cancer to brain disease treatment such as Alzheimer’s disease [1,2] and cosmetic treatment such as skin tightening [3,4].”
BackgroundLibrizzi, L., Uva, L., Raspagliesi, L., Gionso, M., Regondi, M. C., Durando, G., DiMeco, F., de Curtis, M., & Prada, F. U. (2022) · Scientific Reports · doi:10.1038/s41598-022-06791-7 · Cited by 22
Wasielewska, J. M., Chaves, J. C. S., Cabral-da-Silva, M. C., Pecoraro, M., Viljoen, S. J., Nguyen, T. H., Bella, V. L., Oikari, L. E., Ooi, L., & White, A. R. (2024) · Fluids and Barriers of the CNS · doi:10.1186/s12987-024-00565-1 · Cited by 24
Biological effects of blood–brain barrier disruption using a focused ultrasound
Han, M., Hur, Y., Hwang, J., & Park, J. (2017) · Biomedical Engineering Letters · doi:10.1007/s13534-017-0025-4 · Cited by 24
Todd, N., McDannold, N. J., & Borsook, D. (2020) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2020.06.007 · Cited by 22
“…approach was based on pre-clinical results that showed focused ultrasound disruption of the BBB alone helped to reduce plaque burden in an Alzheimer’s disease mouse model, most likely due to the initiation of an immune response at the site of opening (Burgess et al., 2014; Leinenga and Götz, 2015).”
MethodLynch, M., Heinen, S., Markham-Coultes, K., O'Reilly, M., Van Slyke, P., Dumont, D. J., Hynynen, K., & Aubert, I. (2021) · International Journal of Medical Sciences · doi:10.7150/ijms.36775 · Cited by 20
“These endogenous antibodies co-localized with amyloid-β plaques and could contribute to FUS-mediated plaque reduction [11,14,43].”
BackgroundHan, M., Seo, H., Choi, H., Lee, E., & Park, J. (2021) · Frontiers in Neuroscience · doi:10.3389/fnins.2021.685977 · Cited by 23
Silburt, J., & Aubert, I. (2022) · Journal of Neuroinflammation · doi:10.1186/s12974-021-02376-9 · Cited by 22
“CD68 has traditionally been used as a marker of both pro-inflammation [37–39], and general microglial activation [40], and has been shown to be expressed by microglia following FUS [26, 41].”
MethodZhu, Q., Xu, X., Chen, B., Liao, Y., Guan, X., He, Y., Cui, H., Rong, Y., Liu, Z., & Xu, Y. (2022) · Medical Physics · doi:10.1002/mp.15500 · Cited by 21
Li, B., Lin, Y., Chen, G., Cai, M., Zhong, H., Xiao, Z., Lin, M., Li, T., Cai, Y., Shuai, X., et al. (2023) · Advanced Science · doi:10.1002/advs.202302134 · Cited by 23
Shrestha, P., & Klann, E. (2016) · Nature · doi:10.1038/nature17312 · Cited by 22
Pandey, G., Morla, S., Nemade, H. B., Kumar, S., & Ramakrishnan, V. (2019) · RSC Advances · doi:10.1039/c8ra09993f · Cited by 21
Photostimulation of Extravasation of Beta-Amyloid through the Model of Blood-Brain Barrier
Zinchenko, E. M., Klimova, M., Mamedova, A., Agranovich, I., Blokhina, I., Antonova, T., Terskov, A. V., Shirokov, A. A., Наволокин, Н. А., Morgun, A. V., et al. (2020) · Electronics · doi:10.3390/electronics9061056 · Cited by 22
Genetic manipulation of brain endothelial cells in vivo
Assmann, J. C., Körbelin, J., & Schwaninger, M. (2015) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2015.10.006 · Cited by 23
Géraudie, A., Riche, M., Lestra, T., Trotier, A., Dupuis, L., Mathon, B., Carpentier, A. C., & Delatour, B. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms241512411 · Cited by 22
“Our results showed a decrease in microglial loads in P301S mice, which was not reported in previous studies using AD mouse models [25,26,28,29].”
BackgroundResultInfluentialBajracharya, R., Brici, D., Bodea, L., Janowicz, P. W., Götz, J., & Nisbet, R. M. (2021) · Acta Neuropathologica Communications · doi:10.1186/s40478-021-01147-0 · Cited by 20
“Immediately prior to treatment, all animals were anesthetized again and prepared as previously described [19].”
MethodSelf-citationNon-pharmacological treatment of Alzheimer’s disease: an update
Wang, S., Xu, H., Liu, G., & Chen, L.-M. (2025) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2025.1527242 · Cited by 25
“Repeated scanning ultrasound therapy can reduce plaque burden in AD mice and enhance memory function (Leinenga and Götz, 2015).”
Getting ahead of Alzheimer’s disease: early intervention with focused ultrasound
Noel, R. L., Gorman, S. L., Batts, A. J., & Konofagou, E. E. (2023) · Frontiers in Neuroscience · doi:10.3389/fnins.2023.1229683 · Cited by 21
“FUS-BBBO has been shown to increase drug delivery efficiency, promote neurogenesis, stimulate a neuroimmune response, reduce AD pathology, and improve cognition across multiple preclinical, therapeutic studies in late-stage AD models (Burgess et al., 2014; Scarcelli et al., 2014; Leinenga and Götz, 2015; Karakatsani e…”
BackgroundMethodUsing focused ultrasound to modulate microglial structure and function
Grewal, S., de Andrade, E. G., Kofoed, R. H., Matthews, P. M., Aubert, I., Tremblay, M., & Morse, S. V. (2023) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2023.1290628 · Cited by 23
Martinez, P. J., Song, J. J., Garay, F. G., Song, K.-H., Mufford, T., Steiner, J., DeSisto, J. A., Ellens, N. P. K., Serkova, N. J., Green, A. L., et al. (2024) · Scientific Reports · doi:10.1038/s41598-024-67916-8 · Cited by 21
Frustrated peptide chains at the fibril tip control the kinetics of growth of amyloid-β fibrils
Xu, Y., Knapp, K., Le, K. N., Schafer, N. P., Safari, M. S., Davtyan, A., Wolynes, P. G., & Vekilov, P. G. (2021) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2110995118 · Cited by 20
“and dynamics study of amyloid beta peptide (1-42): An in-silico-based analysis to”
BackgroundIntracranial Applications of MR Imaging–Guided Focused Ultrasound
Khanna, N., Gandhi, D., Steven, A. J., Frenkel, V., & Melhem, E. R. (2016) · American Journal of Neuroradiology · doi:10.3174/ajnr.a4902 · Cited by 21
“The etiology of amyloid- plaque reduction is proposed to be related to enhancement of intrinsic microglial phagocytosis.(24)”
BackgroundXie, P., Zhou, S., Wang, X., Wang, Y., & Yuan, Y. (2018) · BMC Neuroscience · doi:10.1186/s12868-018-0462-8 · Cited by 19
Leinenga, G., Bodea, L., Schröder, J., Sun, G., Zhou, Y., Song, J. H., Grubman, A., Polo, J. M., & Götz, J. (2022) · Bioengineering & Translational Medicine · doi:10.1002/btm2.10329 · Cited by 19
“One study reported that plaque reduction can occur as fast as 48 h after BBB opening,(12) and we have shown that this process occurs through microglial phagocytosis.(13) Ultrasound-mediated bioeffects (including microglial activation) have also been demonstrated by specifically targeting the hippocampus,(14,15) but th…”
BackgroundMethodSelf-citationParanjape, A. N., D’Aiuto, L., Zheng, W., Chen, X., & Villanueva, F. S. (2024) · Scientific Reports · doi:10.1038/s41598-023-50203-3 · Cited by 18
“Intriguingly, studies have shown that even without drugs, the use of ultrasound with microbubbles alone reduces amyloid plaques and improves cognitive abilities in mouse models of AD 12,31,54,55 .”
BackgroundExtended detrended fluctuation analysis of sound-induced changes in brain electrical activity
Павлов, А. Н., Dubrovsky, A. I., Koronovskii, A. A., Pavlova, O. N., SEMYACHKINA-GLUSHKOVSKAYA, O. V., & Kurths, J. (2020) · Chaos Solitons & Fractals · doi:10.1016/j.chaos.2020.109989 · Cited by 18
Dong, J., Wang, Z., Yang, F., Wang, H., Cui, X., & Li, Z. (2022) · Advances in Colloid and Interface Science · doi:10.1016/j.cis.2022.102683 · Cited by 19
The neuroprotective effect of focused ultrasound: New perspectives on an old tool
Yuluğ, B., Hanoğlu, L., & Kılıç, E. (2017) · Brain Research Bulletin · doi:10.1016/j.brainresbull.2017.04.015 · Cited by 18
“Anti-amyloid effect and improved memory scores (43,44,90-94)”
ResultSeo, Y., Han, S., Song, B., Chang, J. W., Na, Y. C., & Chang, W. S. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms24065712 · Cited by 18
“This technology has also been reported to regulate immune responses, improve cognitive function, and promote neurogenesis [13,14].”
BackgroundChien, C.-Y., Xu, L., Yuan, J., Fadera, S., Stark, A. H., Athiraman, U., Leuthardt, E. C., & Chen, H. (2024) · EBioMedicine · doi:10.1016/j.ebiom.2024.105066 · Cited by 17
Fisher, D. G., Cruz, T., Hoch, M. R., Sharifi, K. A., Shah, I. M., Gorick, C. M., Breza, V. R., Debski, A. C., Samuels, J. D., Sheehan, J. P., et al. (2025) · Nature Biomedical Engineering · doi:10.1038/s41551-025-01390-z · Cited by 21
“FUS-MB—in the absence of drug delivery—has also exhibited a therapeutic effect in pre-clinical models of Alzheimer’s disease 22–27 .”
Ultrasound Neuromodulation: Integrating Medicine and Engineering for Neurological Disease Treatment
Chen, Y., Li, Y., Du, M., Yu, J., Gao, F., Yuan, Z., & Chen, Z. (2021) · BIO Integration · doi:10.15212/bioi-2020-0026 · Cited by 17
“7 MPa) independently and found that Aβ plaques were cleared in 75% of the ultrasound-treated mice [64].”
BackgroundUltrasound brain stimulation technologies for targeted therapeutics
Jo, Y., Kim, S., Jeong, J., & Lee, H. J. (2025) · Nature Electronics · doi:10.1038/s41928-025-01420-3 · Cited by 26
“Furthermore, techniques for visualizing the beam focus and stimulation effects in the brain have enabled real-time neuronavigational studies using MR, infrared and pulse-average intensity) from 100–1,000 mW cm −2 in LIFU to more than 1,000 W cm −2 in high-intensity focused ultrasound 7,26,28–31 .”
Parkinson's disease gene therapy: Will focused ultrasound and nanovectors be the next frontier?
Price, R. J., Fisher, D. G., Suk, J. S., Hanes, J. S., Ko, H. S., & Kordower, J. H. (2019) · Movement Disorders · doi:10.1002/mds.27675 · Cited by 16
A High-Frequency Phased Array System for Transcranial Ultrasound Delivery in Small Animals
Rahimi, S., Jones, R. M., & Hynynen, K. (2020) · IEEE Transactions on Ultrasonics Ferroelectrics and Frequency Control · doi:10.1109/tuffc.2020.3012868 · Cited by 16
“, neurogenesis [3], [4], amyloidbeta plaque clearance [5]–[7], angiogenesis [8]).”
BackgroundConway, G. E., Paranjape, A. N., Chen, X., & Villanueva, F. S. (2023) · Ultrasound in Medicine & Biology · doi:10.1016/j.ultrasmedbio.2023.12.005 · Cited by 16
Circularity, psychiatry & biomarkers: The operationalisation of Alzheimer's & stress in research
Fletcher, J. R., & Birk, R. H. (2019) · Social Science & Medicine · doi:10.1016/j.socscimed.2019.112553 · Cited by 15
Martínez‐Fernández, R., & Pineda‐Pardo, J. A. (2020) · Current Opinion in Neurology · doi:10.1097/wco.0000000000000840 · Cited by 15
Götz, J., Richter-Stretton, G. L., & Cruz, E. (2021) · Pharmaceutics · doi:10.3390/pharmaceutics13071002 · Cited by 16
“Of note, there was no evidence of overt damage to the brain due to the sonication paradigm [4].”
BackgroundMethodSelf-citationMathew, A. S., Gorick, C. M., & Price, R. J. (2021) · Theranostics · doi:10.7150/thno.65064 · Cited by 15
“nanoparticles) through tissue [36,37], activation of neurogenesis [27,28,30], amyloid-β [20,24] and hyperphosphorylated tau clearance [26], and even sterile inflammation [18,38], which could augment immunotherapies.”
BackgroundResultInfluential
Metadata
- Authors
- Leinenga, G., & Götz, J.
- Affiliations
- The University of Queensland (AU)
- Corresponding author
- Götz, Jürgen
- Venue
- Science Translational Medicine
- Published
- 2015-03-11
- Volume
- 7
- Issue
- 278
- Pages
- 278ra33-278ra33
- ISSN
- 1946-6234 (ISSN-L)
- 1946-6242
- OpenAlex
- W2169076271
- Cited by
- 498
- References
- 40
- Citations by year
- 2026: 24 · 2025: 39 · 2024: 40 · 2023: 50 · 2022: 41 · 2021: 52 · 2020: 51 · 2019: 40 · 2018: 44 · 2017: 55 · 2016: 36 · 2015: 25
- FWCI
- 39.35
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Science Translational Medicine (publishedVersion)
- PubMed (publishedVersion)
- Funders
- Australian Research Council (DP130101932)
- National Health and Medical Research Council of Australia (APP1037746, APP1003150)
- ARC Linkage Infrastructure, Equipment, and Facilities (LE130100078)
- Topics
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Alzheimer's disease research and treatments
- Physical Sciences › Engineering › Biomedical Engineering › Ultrasound and Hyperthermia Applications
- Life Sciences › Neuroscience › Neurology › Neuroinflammation and Neurodegeneration Mechanisms
- Keywords
- Alzheimer's disease, amyloid-beta, non-pharmacological treatment, amyloid plaque clearance, microglia, memory recovery, mouse model
- MeSH terms
- Albumins, Alzheimer Disease, Animals, Blood-Brain Barrier, Cell Count, Disease Models, Animal, Humans, Inflammation, Lysosomes, Memory, Mice, Inbred C57BL, Mice, Transgenic, Phagocytosis, Ultrasonography, Ultrasonics, Amyloid beta-Peptides, Microglia, Plaque, Amyloid
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.